Rifabutin

Rifabutin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the prevention of disseminated Mycobacterium avium complex (MAC) infection in people with advanced HIV infection. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Rifabutina and Mycobutin. Its PubChem CID is 135415564.

CAS No 72559-06-9
Molecular Formula C46H62N4O11
Molecular Weight 847.0 g/mol
Synonyms [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] acetate

Frequently Asked Questions